Quan Zhou Net Worth & Insider Trades

Quan Zhou - Director, Casi Pharmaceuticals, Inc

As of May 26, 2022

What is Quan Zhou's Net Worth?

The current estimated net worth of Casi Pharmaceuticals, Inc's Director, Quan Zhou, is estimated to be about $3.16M . Quan Zhou owns about 646,995 units of Casi Pharmaceuticals, Inc common stock. In the last 6 years at Casi Pharmaceuticals, Inc, Quan Zhou has sold an estimated value of $0 worth.

What is Quan Zhou's Past Insider Trading?

Quan Zhou's largest purchase order was 3,086,418 units , worth over $9.85M on March 23, 2018. In total, Quan Zhou has made about 9 transactions over 6 years of their time at Casi Pharmaceuticals, Inc. Quan Zhou usually trades in June, with the busiest year in 2016 and 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Quan Zhou's' Mailing Address?

  • Mailing address is C/o Idg VC Management Ltd. Unit 1509, the Center, 99 Queen'S Rd Central K3 - Hong Kong

Casi Pharmaceuticals, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Wei-Wu He, Ph.D. 2020 $577,656 - - - - $241,831 $819,487
Wei-Wu He, Ph.D. 2019 $423,848 - - $8,600,000 - $241,555 $9,265,103
Wei (Larry) Zhang 2020 $437,094 - - - - $278,675 $715,769
Wei (Larry) Zhang 2019 $339,207 - - $450,000 - $166,889 $985,186
Alexander Zukiwski, MD 2020 $414,529 - - - - $28,250 $442,779
Alexander Zukiwski, MD 2019 $407,600 $100,000 - $426,000 - $27,750 $961,350
Weihao Xu 2020 $14,583 - - $1,440,000 - - $1,454,583
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/895051/000110465921063604/tm2114348d2_def14a.htm

What are Casi Pharmaceuticals, Inc's Past Insider Trades?

Casi Pharmaceuticals, Inc's most recent insider trade came on September 8, 2022 by James Huang who bought 55,573 units worth $229.66K . In the last 6 years, insiders at Casi Pharmaceuticals, Inc have sold an estimated value of $5.53M and bought an estimated value of $56.36M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Wei-Wu He, Chairman and CEO,  James Huang, Director,  and Cynthia W Hu, COO .

CASI Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found